SAM #75F40126Q00337

FDA Sole Source Procurement of Z-Spec Z-max and E-max PLUS Analyzers

This notice announces the FDA's intent to issue a sole source contract to Z-Spec, Inc. for specialized laboratory analyzers. - Agency: U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), Human Food Program (HFP) - Sole source procurement to Z-Spec, Inc. for: - 1 Z-max Analyzer (part number 106-01) - 1 E-max PLUS Analyzer (part number 102-02) - Accessories including sample cups, preparation kit, transporting case, and standards kit - Both analyzers are portable X-ray fluorescence spectrometers using patented HDXRF and MXRF technologies - Designed for rapid detection and quantification of toxic elements (arsenic, cadmium, mercury, lead) in food, dietary supplements, cosmetics, spices, soil, and water - Meet FDA Human Food Program's ultra-low detection requirements - Services included: - Installation, set-up, and initial calibration - One-day onsite training by a field application scientist - Period of performance: 12 months, estimated from September 30, 2026 to September 29, 2027 - No other OEMs or competing products are mentioned; Z-Spec, Inc. is specified as the only source - Commercial opportunity is limited due to sole source justification, but similar XRF analyzer manufacturers may be interested in future opportunities

Description

The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), intends to award a sole source, firm-fixed-price purchase order to Z-Spec, Inc. (15 Tech Valley Drive, Suite 110 East Greenbush, NY 12061) for the acquisition of the following brand-name commercial items Z-max and E-max PLUS Analyzers.

View original listing